91 related articles for article (PubMed ID: 2068150)
1. Characterization of neuropeptide Y in pediatric neural crest tumors: relation to tumor malignancy and genetic findings.
Kogner P; Björk O; Hedborg F; Nordenskjöld A; Nordenskjöld M; Söderhäll S; Theodorsson E
Prog Clin Biol Res; 1991; 366():351-7. PubMed ID: 2068150
[No Abstract] [Full Text] [Related]
2. Plasma neuropeptide Y (NPY): a novel marker of neuroblastoma.
Kogner P; Theodorsson E; Björk O
Prog Clin Biol Res; 1991; 366():367-73. PubMed ID: 2068152
[No Abstract] [Full Text] [Related]
3. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
4. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
5. Significance of plasma neuropeptide Y (NPY) in diagnosis and prognosis of neuroblastoma.
Hayashi Y; Ohi R; Sone M; Takahashi K; Mouri T; Watanabe T; Yaoita S; Nakamura M
Prog Clin Biol Res; 1991; 366():359-65. PubMed ID: 2068151
[No Abstract] [Full Text] [Related]
6. Loss of heterozygosity on chromosome 14 in neuroblastoma.
Suzuki T; Mugishima H; Fujisawa T; Okuni M; Okabe I; Yokota J; Terada M
Prog Clin Biol Res; 1991; 366():135-45. PubMed ID: 2068134
[No Abstract] [Full Text] [Related]
7. The impact of tumor histology on treatment and prognosis of pediatric neoplasms.
Beckwith JB
Semin Pediatr Surg; 1993 Feb; 2(1):11-8. PubMed ID: 8062017
[No Abstract] [Full Text] [Related]
8. [Intrathoracic tumors of the sympathetic nervous system--characteristics of their biological behavior].
Anders M; Lorenz G; Reddemann H
Padiatr Grenzgeb; 1988; 27(6):503-9. PubMed ID: 3237421
[No Abstract] [Full Text] [Related]
9. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
[TBL] [Abstract][Full Text] [Related]
10. Tumors of the neuroblastoma group.
Shimada H
Pathology (Phila); 1993; 2(1):43-59. PubMed ID: 9420930
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome.
Grosfeld JL; Rescorla FJ; West KW; Goldman J
Semin Pediatr Surg; 1993 Feb; 2(1):37-46. PubMed ID: 8062021
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts.
Kogner P; Björk O; Theodorsson E
Med Pediatr Oncol; 1993; 21(5):317-22. PubMed ID: 8492745
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y as a marker in pediatric neuroblastoma.
Kogner P; Björk O; Theodorsson E
Pediatr Pathol; 1990; 10(1-2):207-16. PubMed ID: 2315229
[TBL] [Abstract][Full Text] [Related]
14. Screening for neuroblastoma: progress and pitfalls.
Ross JA; Davies SM
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):189-94. PubMed ID: 10067819
[No Abstract] [Full Text] [Related]
15. Neuropeptide Y as a plasma marker for phaeochromocytoma, ganglioneuroblastoma and neuroblastoma.
Mouri T; Sone M; Takahashi K; Itoi K; Totsune K; Hayashi Y; Hasegawa S; Ohneda M; Murakami O; Miura Y
Clin Sci (Lond); 1992 Aug; 83(2):205-11. PubMed ID: 1327637
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
[TBL] [Abstract][Full Text] [Related]
17. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric DNA analysis of neuroblastoma: prognostic significance of DNA ploidy in unfavorable group.
Naito M; Iwafuchi M; Ohsawa Y; Uchiyama M; Hirota M; Matsuda Y; Iinuma Y
J Pediatr Surg; 1991 Jul; 26(7):834-7. PubMed ID: 1895194
[TBL] [Abstract][Full Text] [Related]
19. Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics.
Hiyama E; Hiyama K; Yokoyama T; Ichikawa T; Matsuura Y
Jpn J Cancer Res; 1992 Feb; 83(2):159-64. PubMed ID: 1555997
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology and genetics of neuroblastoma.
Tay JS
J Singapore Paediatr Soc; 1991; 33(3-4):80-7. PubMed ID: 1812339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
